In vivo experiments indicate that the absence of GINS4 can suppress tumor growth in HCC, increase the expression of GPX4, and decrease the levels of Ki67, while also reducing the activity of the POLE2/PI3K/AKT signaling pathway (101). This evidence concerns the gene AKT1 and hepatocellular carcinoma.